FDA approves Cosentyx, a New Psoriasis Drug!
Dr. Quyn Rahman2015-01-22T22:50:57-05:00Today, the FDA approved Novartis’ drug Cosentyx (secukinumab), which is used to treat adults with moderate to severe plaque psoriasis, a skin disease caused by problems with the immune system. Cosentryx is an injectable treatment, and is the first drug to be approved to block the IL-17 protein, which plays a role in inflammation. Some [...]